CLL
News
Global data suggest rising CLL incidence since 1990
New global data show the rate of chronic lymphocytic leukemia increasing in the last 30 years. Is ascertainment bias a factor?
News
Researchers tout new CLL prognostic tool
CLL-CI relies on comorbidity scoring to predict levels of risk linked to survival, time to treatment.
News
Women at higher risk of serious adverse events from cancer therapy
As cancer treatment becomes increasingly individualized, “sex may be an important consideration.”
News
Stopping venetoclax treatment early reduces CLL survival outcomes
Survival outcomes are decreased with early, permanent discontinuation of venetoclax but unchanged by treatment interruption, regardless of...
News
FDA investigates possible increased risk of death with lymphoma drug
Clinical trial findings of “possible increased risk of death” associated with the drug umbralisib for CLL prompted the FDA to announce...
News
CLL patients ‘cured’: 10 years post infusion, CAR T cells persist
A decade after CAR T’cell treatment, chronic leukemia patients reported “cured,” with cells still detectable.
News
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
News
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
News
‘Highly encouraging’ MRD results for zanubrutinib add-on in CLL
Blood and bone marrow MRD was undetectable in almost 90% of subjects after a median of 10 treatment cycles.
News
CLL and COVID-19: Outcome trends and lessons learned
Data highlight opportunities for further investigation into optimal management of COVID-19, immune response after infection, and effective...